Research analysts at Guggenheim began coverage on shares of Compass Therapeutics (NASDAQ:CMPX – Get Free Report) in a research note issued on Monday, MarketBeat reports. The firm set a “buy” rating ...

A case study on how one of the leading pharma companies in the oncology space approached DelveInsight with a pressing need for conference coverage to monitor the activities and data readouts of ...

Good morning, Boston. Are you enjoying this warmer weather? I grilled hamburgers and a steak for dinner last night, and it was great. Here are the five things you need to know in local business news ...